BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26087198)

  • 1. Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.
    Visco C; Falisi E; Young KH; Pascarella M; Perbellini O; Carli G; Novella E; Rossi D; Giaretta I; Cavallini C; Scupoli MT; De Rossi A; D'Amore ES; Rassu M; Gaidano G; Pizzolo G; Ambrosetti A; Rodeghiero F
    Oncotarget; 2015 Jul; 6(21):18653-63. PubMed ID: 26087198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Associated with Unfavorable Prognosis.
    Grywalska E; Roliński J; Pasiarski M; Korona-Glowniak I; Maj M; Surdacka A; Grafka A; Stelmach-Gołdyś A; Zgurski M; Góźdź S; Malm A; Grabarczyk P; Starosławska E
    PLoS One; 2015; 10(10):e0140178. PubMed ID: 26460692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia.
    Liang JH; Gao R; Xia Y; Gale RP; Chen RZ; Yang YQ; Wang L; Qu XY; Qiu HR; Cao L; Hong M; Wang R; Wang Y; Fan L; Chen YY; Hu ZB; Li JY; Xu W
    Oncotarget; 2016 Jan; 7(2):2135-42. PubMed ID: 26539641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
    Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
    J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
    Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
    Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.
    Alfieri S; Iacovelli NA; Marceglia S; Lasorsa I; Resteghini C; Taverna F; Mazzocchi A; Orlandi E; Guzzo M; Bianchi R; Fanti D; Pala L; Racca S; Dvir R; Quattrone P; Gloghini A; Volpi CC; Granata R; Bergamini C; Locati L; Licitra L; Bossi P
    Oncotarget; 2017 Jul; 8(29):47780-47789. PubMed ID: 28562354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Lu Y; Sun LR; Pang XY; Lu ZH; Sui AH
    Ai Zheng; 2007 Jan; 26(1):54-7. PubMed ID: 17222368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection in Richter's transformation.
    Ansell SM; Li CY; Lloyd RV; Phyliky RL
    Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients.
    Hassen E; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Chouchane L
    Biomarkers; 2011 May; 16(3):274-80. PubMed ID: 21506698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection.
    Nakai H; Kawamura Y; Sugata K; Sugiyama H; Enomoto Y; Asano Y; Ihira M; Ohashi M; Kato T; Yoshikawa T
    Microbiol Immunol; 2012 Feb; 56(2):93-8. PubMed ID: 22150751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma.
    Leung SF; Chan KC; Ma BB; Hui EP; Mo F; Chow KC; Leung L; Chu KW; Zee B; Lo YM; Chan AT
    Ann Oncol; 2014 Jun; 25(6):1204-8. PubMed ID: 24638904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection.
    de Leval L; Vivario M; De Prijck B; Zhou Y; Boniver J; Harris NL; Isaacson P; Du MQ
    Am J Surg Pathol; 2004 May; 28(5):679-86. PubMed ID: 15105659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
    Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
    J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and Epstein Barr virus (EBV) genes expression in blood chronic lymphocytic leukaemia (CLL) cells and their immortalised CLL cell lines.
    Laytragoon-Lewin N; Chen F; Castro J; Avila-Carino J; Lewin F
    Anticancer Res; 2003; 23(5A):4017-22. PubMed ID: 14666712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.